Synthesis and characterization of heteroleptic Cr(diimine)33+ complexes von Barker, Kylie D., Barnett, Kristin A., Connell, Stuart M., Glaeser, Jeff W., Wallace, Amy Jo, Wildsmith, Justin, Herbert, Brad J., Wheeler, John F., Kane-Maguire, Noel A.P.

Volltext

Synthesis and characterization of heteroleptic Cr(diimine) 3 3+ complexes von Barker, Kylie D., Barnett, Kristin A., Connell, Stuart M., Glaeser, Jeff W., Wallace, Amy Jo, Wildsmith, Justin, Herbert, Brad J., Wheeler, John F., Kane-Maguire, Noel A.P.

Volltext

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial von Pusztai, Lajos, Yau, Christina, Wolf, Denise M., Han, Hyo S., Du, Lili, Wallace, Anne M., String-Reasor, Erica, Boughey, Judy C., Chien, A. Jo, Elias, Anthony D., Beckwith, Heather, Nanda, Rita, Albain, Kathy S., Clark, Amy S., Kemmer, Kathleen, Kalinsky, Kevin, Isaacs, Claudine, Thomas, Alexandra, Shatsky, Rebecca, Helsten, Theresa L., Forero-Torres, Andres, Liu, Minetta C., Brown-Swigart, Lamorna, Petricoin, Emmanuel F., Wulfkuhle, Julia D., Asare, Smita M., Wilson, Amy, Singhrao, Ruby, Sit, Laura, Hirst, Gillian L., Berry, Scott, Sanil, Ashish, Asare, Adam L., Matthews, Jeffrey B., Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Yee, Doug, van’t Veer, Laura J., Hylton, Nola M., DeMichele, Angela M., Berry, Donald A., Esserman, Laura J.

Volltext

The Impact of Racism on Child and Adolescent Health von Trent, Maria, Dooley, Danielle G, Dougé, Jacqueline

Volltext

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients von Yau, Christina, van der Noordaa, Marieke, Shad, Sonal, de Croze, Diane, Hamy, Anne-Sophie, Laé, Marick, Reyal, Fabien, Sonke, Gabe S, Steenbruggen, Tessa G, van Seijen, Maartje, Wesseling, Jelle, del Monte-Millán, Maria, López-Tarruella, Sara, Albain, Kathy S., Asare, Smita M., Balassanian, Ron, Beckwith, Heather, Berry, Scott M., Berry, Donald A., Boughey, Judy C., Buxton, Meredith B., Chen, Yunn-Yi, Chen, Beiyun, Clark, Amy S., Clennell, Julia L., DeMichele, Angela M., Duan, Xiuzhen, Edmiston, Kirsten K., Ellis, Erin D., Esserman, Laura L., Euhus, David M., Fan, Fang, Feldman, Michael D, Han, Hyo S., Haugen, Patricia, Helsten, Teresa, Hylton, Nola M., Isaacs, Claudine, Kemmer, Kathleen, Khazai, Laila, Klein, Molly E., Krings, Gregor, Leyland-Jones, Brian, Liu, Minetta C., Lo, Shelly, Lu, Janice, Magliocco, Anthony, Melisko, Michelle E., Mhawech-Fauceglia, Paulette, Moulder, Stacy L., Murthy, Rashmi K., Nanda, Rita, Ocal, Idris T., Olopade, Olufunmilayo, Pambuccian, Stefan, Paoloni, Melissa, Park, John W., Perlmutter, Jane, Peterson, Garry, Rendi, Mara, Rugo, Hope S., Sams, Sharon, Sattar, Husain, Schwab, Richard B., Singhrao, Ruby, Steeg, Katherine, Stringer-Reasor, Erica, Symmans, W. Fraser, Tripathy, Debasish, Troxell, Megan L., van't Veer, Laura J., Venters, Sara J., Vinh, Tuyethoa, Viscusi, Rebecca K., Wallace, Anne M., Wei, Shi, Wilson, Amy, Yau, Christina, Zeck, Jay C., Boughey, Judy C, Goetz, Matthew P, Hoskin, Tanya, Gould, Rebekah, Edge, Stephen B, Abraham, Jean E, Bartlett, John M S, Caldas, Carlos, Dunn, Janet, Hayward, Larry, Provenzano, Elena, Mackintosh, Lorna, Fan, Fang, Schwensen, Kelsey, Sharma, Priyanka, DeMichele, Angela M, Cole, Kimberly, Pusztai, Lajos, Kim, Mi-Ok, van 't Veer, Laura J, Symmans, W Fraser

Volltext

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers i... von Chien, A Jo, Tripathy, Debasish, Albain, Kathy S, Symmans, W Fraser, Rugo, Hope S, Melisko, Michelle E, Wallace, Anne M, Schwab, Richard, Helsten, Teresa, Forero-Torres, Andres, Stringer-Reasor, Erica, Ellis, Erin D, Kaplan, Henry G, Nanda, Rita, Jaskowiak, Nora, Murthy, Rashmi, Godellas, Constantine, Boughey, Judy C, Elias, Anthony D, Haley, Barbara B, Kemmer, Kathleen, Isaacs, Claudine, Clark, Amy S, Lang, Julie E, Lu, Janice, Korde, Larissa, Edmiston, Kirsten K, Northfelt, Donald W, Viscusi, Rebecca K, Yee, Douglas, Perlmutter, Jane, Hylton, Nola M, Van't Veer, Laura J, DeMichele, Angela, Wilson, Amy, Peterson, Garry, Buxton, Meredith B, Paoloni, Melissa, Clennell, Julia, Berry, Scott, Matthews, Jeffrey B, Steeg, Katherine, Singhrao, Ruby, Hirst, Gillian L, Sanil, Ashish, Yau, Christina, Asare, Smita M, Berry, Donald A, Esserman, Laura J

Volltext

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-... von Magbanua, Mark Jesus M., van ‘t Veer, Laura, Clark, Amy S., Chien, A. Jo, Boughey, Judy C., Han, Hyo S., Wallace, Anne, Beckwith, Heather, Liu, Minetta C., Yau, Christina, Wileyto, E. Paul, Ordonez, Andrea, Solanki, Tulasi I., Hsiao, Feng, Lee, Jen Chieh, Basu, Amrita, Brown Swigart, Lamorna, Perlmutter, Jane, Delson, Amy L., Bayne, Lauren, Deluca, Shannon, Yee, Stephanie S., Carpenter, Erica L., Esserman, Laura J., Park, John W., Chodosh, Lewis A., DeMichele, Angela

Volltext

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial von Khoury, Katia, Meisel, Jane L., Yau, Christina, Rugo, Hope S., Nanda, Rita, Davidian, Marie, Tsiatis, Butch, Chien, A. Jo, Wallace, Anne M., Arora, Mili, Rozenblit, Mariya, Hershman, Dawn L., Zimmer, Alexandra, Clark, Amy S., Beckwith, Heather, Elias, Anthony D., Stringer-Reasor, Erica, Boughey, Judy C., Nangia, Chaitali, Vaklavas, Christos, Omene, Coral, Albain, Kathy S., Kalinsky, Kevin M., Isaacs, Claudine, Tseng, Jennifer, Roussos Torres, Evanthia T., Thomas, Brittani, Thomas, Alexandra, Sanford, Amy, Balassanian, Ronald, Ewing, Cheryl, Yeung, Kay, Sauder, Candice, Sanft, Tara, Pusztai, Lajos, Trivedi, Meghna S., Outhaythip, Ashton, Li, Wen, Onishi, Natsuko, Asare, Adam L., Beineke, Philip, Norwood, Peter, Brown-Swigart, Lamorna, Hirst, Gillian L., Matthews, Jeffrey B., Moore, Brian, Fraser Symmans, W., Price, Elissa, Beedle, Carolyn, Perlmutter, Jane, Pohlmann, Paula, Shatsky, Rebecca A., DeMichele, Angela, Yee, Douglas, van ‘t Veer, Laura J., Hylton, Nola M., Esserman, Laura J.

Volltext

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial von Shatsky, Rebecca A., Trivedi, Meghna S., Yau, Christina, Nanda, Rita, Rugo, Hope S., Davidian, Marie, Tsiatis, Butch, Wallace, Anne M., Chien, A. Jo, Stringer-Reasor, Erica, Boughey, Judy C., Omene, Coral, Rozenblit, Mariya, Kalinsky, Kevin, Elias, Anthony D., Vaklavas, Christos, Beckwith, Heather, Williams, Nicole, Arora, Mili, Nangia, Chaitali, Roussos Torres, Evanthia T., Thomas, Brittani, Albain, Kathy S., Clark, Amy S., Falkson, Carla, Hershman, Dawn L., Isaacs, Claudine, Thomas, Alexandra, Tseng, Jennifer, Sanford, Amy, Yeung, Kay, Boles, Sarah, Chen, Yunni Yi, Huppert, Laura, Jahan, Nusrat, Parker, Catherine, Giridhar, Karthik, Howard, Frederick M., Blackwood, M. Michele, Sanft, Tara, Li, Wen, Onishi, Natsuko, Asare, Adam L., Beineke, Philip, Norwood, Peter, Brown-Swigart, Lamorna, Hirst, Gillian L., Matthews, Jeffrey B., Moore, Brian, Symmans, W. Fraser, Price, Elissa, Heditsian, Diane, LeStage, Barbara, Perlmutter, Jane, Pohlmann, Paula, DeMichele, Angela, Yee, Douglas, van ’t Veer, Laura J., Hylton, Nola M., Esserman, Laura J.

Volltext

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer von Rugo, Hope S, Campbell, Mike, Yau, Christina, Jo Chien, A, Wallace, Anne M, Isaacs, Claudine, Boughey, Judy C, Han, Hyo S, Buxton, Meredith, Clennell, Julia L, Asare, Smita M, Steeg, Katherine, Wilson, Amy, Singhrao, Ruby, Matthews, Jeffrey B, Perlmutter, Jane, Fraser Symmans, W, Hylton, Nola M, DeMichele, Angela M, Yee, Douglas, Van't Veer, Laura J, Berry, Donald A, Esserman, Laura J

Volltext

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial von Clark, Amy S., Yau, Christina, Wolf, Denise M., Petricoin, Emanuel F., van ‘t Veer, Laura J., Yee, Douglas, Moulder, Stacy L., Wallace, Anne M., Chien, A. Jo, Isaacs, Claudine, Boughey, Judy C., Albain, Kathy S., Kemmer, Kathleen, Haley, Barbara B., Han, Hyo S., Forero-Torres, Andres, Elias, Anthony, Lang, Julie E., Ellis, Erin D., Yung, Rachel, Tripathy, Debu, Nanda, Rita, Wulfkuhle, Julia D., Brown-Swigart, Lamorna, Gallagher, Rosa I., Helsten, Teresa, Roesch, Erin, Ewing, Cheryl A., Alvarado, Michael, Crane, Erin P., Buxton, Meredith, Clennell, Julia L., Paoloni, Melissa, Asare, Smita M., Wilson, Amy, Hirst, Gillian L., Singhrao, Ruby, Steeg, Katherine, Asare, Adam, Matthews, Jeffrey B., Berry, Scott, Sanil, Ashish, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope S., Schwab, Richard B., Symmans, W. Fraser, Hylton, Nola M., Berry, Donald A., Esserman, Laura J., DeMichele, Angela M.

Volltext

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2 von Nanda, Rita, Liu, Minetta C., Yau, Christina, Asare, Smita, Hylton, Nola, Veer, Laura Van't, Perlmutter, Jane, Wallace, Anne M., Chien, Amy Jo, Forero-Torres, Andres, Ellis, Erin, Han, Heather, Sanders Clark, Amy, Albain, Kathy S., Caroline Boughey, Judy, Elias, Anthony D., Berry, Donald A., Yee, Douglas, DeMichele, Angela, Esserman, Laura

Volltext

A Consensus Statement for the Management and Rehabilitation of Communication and Swallowing Function in the ICU: A Global Response to COVID-19 von Freeman-Sanderson, Amy, Ward, Elizabeth C., Miles, Anna, de Pedro Netto, Irene, Duncan, Sallyanne, Inamoto, Yoko, McRae, Jackie, Pillay, Natasha, Skoretz, Stacey A., Walshe, Margaret, Brodsky, Martin B., Archer, Sally K., Baker, Sonia, Bergström, Liza, Burns, Clare L., Cameron, Tanis, Cimoli, Michelle, Clayton, Nicola A., Clunie, Gemma, Cole, Therese, Dawson, Camilla, Dikeman, Karen, Duggan, Brooke, Engelbrecht, Leanie, Langton-Frost, Nicole, Hemsley, Bronwyn, Kalf, Hanneke, Kazandjian, Marta, Lakha, Sunaina, Marvin, Stevie, McIntyre, Melanie, Puntil-Sheltman, Jo, do Nascimento Junior, José Ribamar, Suiter, Debra M., Sutt, Anna-Liisa, Wallace, Sarah, Zaga, Charissa J.

Volltext

Abstract GS4-02: Analysis of clinical outcomes and expression-based immune signatures by race in the I-SPY 2 trial von Kyalwazi, Beverly, Yau, Christina, Olopade, Olufunmilayo, Chien, A. Jo, Wallace, Anne, Forero-Torres, Andres, Pusztai, Lajos, Ellis, Erin, Albain, Kathy, Blaes, Anne, Haley, Barbara, Boughey, Judy, Elias, Anthony, Clark, Amy, Isaacs, Claudine, Nanda, Rita, Han, Hyo, Yung, Rachel, Tripathy, Debu, Edmiston, Kristen, Viscusi, Rebecca, Northfelt, Donald, Khan, Qamar, Sanil, Ashish, Berry, Scott, Asare, Smita, Wilson, Amy, Hirst, Gillian, Hylton, Nola, Melisko, Michelle, Perlmutter, Jane, Rugo, Hope, Symmans, Fraser, van ‘t Veer, Laura, Berry, Donald, Esserman, Laura

Volltext

Evaluation of intra-tumoral (IT) SD-101 and pembrolizumab (Pb) in combination with paclitaxel (P) followed by AC in high-risk HER2-negative (HER2-) stage II/III breast cancer: Resu... von Chien, Amy Jo, Soliman, Hatem Hussein, Ewing, Cheryl Ann, Boughey, Judy Caroline, Campbell, Michael J., Rugo, Hope S., Wallace, Anne M., Albain, Kathy S., Stringer-Reasor, Erica Michelle, Church, An L, Kalinsky, Kevin, Elias, Anthony D., Mitri, Zahi Ibrahim, Clark, Amy Sanders, Nanda, Rita, Thomas, Alexandra, Yau, Christina, Berry, Donald A, Esserman, Laura

Volltext

Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer von Kyalwazi, Beverly, Yau, Christina, Campbell, Michael J, Yoshimatsu, Toshio F, Chien, A Jo, Wallace, Anne M, Forero-Torres, Andres, Pusztai, Lajos, Ellis, Erin D, Albain, Kathy S, Blaes, Anne H, Haley, Barbara B, Boughey, Judy C, Elias, Anthony D, Clark, Amy S, Isaacs, Claudine J, Nanda, Rita, Han, Hyo S, Yung, Rachel L, Tripathy, Debasish, Edmiston, Kristen K, Viscusi, Rebecca K, Northfelt, Donald W, Khan, Qamar J, Asare, Smita M, Wilson, Amy, Hirst, Gillian L, Lu, Ruixiao, Symmans, William Fraser, Yee, Douglas, DeMichele, Angela M, van 't Veer, Laura J, Esserman, Laura J, Olopade, Olufunmilayo I

Volltext

Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL von Beckwith, Heather, Schwab, Richard, Yau, Christina, Stringer-Reasor, Erica, Wei, Shi, Chien, A. Jo, Albain, Kathy S, Kalinsky, Kevin, Wallace, Anne, Elias, Anthony, Yee, Douglas, Clark, Amy S, Boughey, Judy C, Han, Heather, Nanda, Rita, Isaacs, Claudine, Mitri, Zahi, Lang, Julie E, Thomas, Alexandra, Sanft, Tara, DeMichele, Angela, Perlmutter, Jane, Rugo, Hope S, Hylton, Nola M, Symmans, W. Fraser, Melisko, Michelle E, van't Veer, Laura J, Wilson, Amy, Asare, Smita M, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoa... von Helsten, Teresa L, Lo, Shelly S, Yau, Christina, Kalinsky, Kevin, Elias, Anthony D, Wallace, Anne M, Chien, A. Jo, Lu, Janice, Lang, Julie E, Albain, Kathy S, Stringer-Reasor, Erica, Clark, Amy S, Boughey, Judy C, Ellis, Erin D, Yee, Douglas, DeMichele, Angela, Isaacs, Claudine, Perlmutter, Jane, Rugo, Hope S, Schwab, Richard, Hylton, Nola M., Symmans, W. Fraser, Melisko, Michelle E, van't Veer, Laura J, Wilson, Amy, Singhrao, Ruby, Asare, Smita M, Sanil, Ashish, Berry, Donald A, Esserman, Laura J

Volltext

Abstract PS2-07: Outcomes associated with disseminated tumor cells at surgery after neoadjuvant chemotherapy in high-risk early stage breast cancer: The I-SPY SURMOUNT study von Magbanua, Mark Jesus M, van 't Veer, Laura, Clark, Amy, Chien, A. Jo, Boughey, Judy, Han, Heather, Wallace, Anne, Beckwith, Heather, Liu, Minetta, Yau, Christina, Wileyto, E. Paul, Swigart, Lamorna Brown, Perlmutter, Jane, Bayne, Lauren, Deluca, Shannon, Yee, Stephanie, Carpenter, Erica, Esserman, Laura, Park, John, Chodosh, Lewis, DeMichele, Angela

Volltext

Abstract CT011: Evaluation of durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL von Pusztai, Lajos, Han, Hyo S., Yau, Christina, Wolf, Denise, Wallace, Anne M., Shatsky, Rebecca, Helsten, Teresa, Boughey, Judy C., Haddad, Tufia, Stringer-Reasor, Erica, Falkson, Carla, Chien, A. Jo, Mukhtar, Rita, Elias, Anthony, Virginia, Borges, Nanda, Rita, Yee, Douglas, Kalinsky, Kevin, Albain, Kathy S., Muller, Aixa Soyano, Kemmer, Kathleen, Clark, Amy S., Isaacs, Claudine, Thomas, Alexandra, Hylton, Nola, Symmans, W. Fraser, Perlmutter, Jane, Melisko, Michelle, Rugo, Hope S., Schwab, Richard, Wilson, Amy, Singhrao, Ruby, Asare, Smita, van't Veer, Laura J., DeMichele, Angela M., Sanil, Ashish, Berry, Donald A., Esserman, Laura J.

Volltext